Yehuda Reznick is Director of ORAMED PHARMACEUTICALS INC.. Currently has a direct ownership of 105,180 shares of ORMP, which is worth approximately $250,328. The most recent transaction as insider was on Dec 31, 2025, when has been sold 36,250 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 105K
52.59% 3M change
244.18% 12M change
Total Value Held $250,328

Yehuda Reznick Transaction History

Date Transaction Value Shares Traded Shares Held Form
Dec 31 2025
BUY
Grant, award, or other acquisition
-
36,250 Added 25.63%
105,180 Common Stock
Jun 05 2025
BUY
Grant, award, or other acquisition
-
38,370 Added 35.76%
68,930 Common Stock
Jun 06 2024
BUY
Grant, award, or other acquisition
-
760 Added 2.43%
30,560 Common Stock
Apr 17 2024
BUY
Grant, award, or other acquisition
-
29,800 Added 50.0%
29,800 Common Stock
YR

Yehuda Reznick

Director
New York, NY

Track Institutional and Insider Activities on ORMP

Follow ORAMED PHARMACEUTICALS INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ORMP shares.

Notify only if

Insider Trading

Get notified when an Oramed Pharmaceuticals Inc. insider buys or sells ORMP shares.

Notify only if

News

Receive news related to ORAMED PHARMACEUTICALS INC.

Track Activities on ORMP